Two research project collaborations – one in diabetes and one in oncology – have been launched, with a total investment of €2.5 million. These are the first projects launched by BiovelocITA, the Italian biotech accelerator launched last year by the chemist and entrepreneur Silvano Spinelli, Gabriella Camboni and the venture capital firm Sofinnova Partners.
/wp-content/uploads/2019/10/logo_enthera.svg00hearten/wp-content/uploads/2019/10/logo_enthera.svghearten2016-11-23 09:10:362020-07-28 11:25:19BiovelocITA, the Italian biotech accelerator, launches two companies, one against diabetes, the other against cancer
BiovelocITA, the Italian biotech accelerator, launches two companies, one against diabetes, the other against cancer
/in Press Releases /by heartenTwo research project collaborations – one in diabetes and one in oncology – have been launched, with a total investment of €2.5 million. These are the first projects launched by BiovelocITA, the Italian biotech accelerator launched last year by the chemist and entrepreneur Silvano Spinelli, Gabriella Camboni and the venture capital firm Sofinnova Partners.